Atrial fibrillation and chronic kidney disease: A bad combination.
作者信息
Kiuchi Márcio Galindo
机构信息
Department of Artificial Cardiac Stimulation and Electrophysiology, Cardiostim, Niterói, RJ, Brazil.
出版信息
Kidney Res Clin Pract. 2018 Jun;37(2):103-105. doi: 10.23876/j.krcp.2018.37.2.103. Epub 2018 Jun 30.
Abstract
摘要
相似文献
1
Atrial fibrillation and chronic kidney disease: A bad combination.
Kidney Res Clin Pract. 2018 Jun;37(2):103-105. doi: 10.23876/j.krcp.2018.37.2.103. Epub 2018 Jun 30.
2
Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues.
Anatol J Cardiol. 2022 Dec;26(12):857-863. doi: 10.5152/AnatolJCardiol.2022.2426.
3
Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation.
Dtsch Arztebl Int. 2018 Apr 27;115(17):287-294. doi: 10.3238/arztebl.2018.0287.
4
Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
BMJ. 2018 Feb 14;360:k342. doi: 10.1136/bmj.k342.
5
Intersection of cardiovascular disease and kidney disease: atrial fibrillation.
Curr Opin Nephrol Hypertens. 2014 May;23(3):275-82. doi: 10.1097/01.mnh.0000444820.80249.56.
6
Atrial fibrillation and heart failure: a bad combination.
Curr Opin Cardiol. 2015 Mar;30(2):161-167. doi: 10.1097/HCO.0000000000000144.
7
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Am J Med. 2019 Sep;132(9):1078-1083. doi: 10.1016/j.amjmed.2019.04.013. Epub 2019 May 2.
8
The effect of concomitant chronic kidney disease on the recurrence of atrial fibrillation after catheter ablation: A protocol for systematic review and meta-analysis.
Medicine (Baltimore). 2021 May 21;100(20):e25903. doi: 10.1097/MD.0000000000025903.
9
Atrial fibrillation and chronic kidney disease: A review of options for therapeutic anticoagulation to reduce thromboembolism risk.
Clin Cardiol. 2018 Oct;41(10):1395-1402. doi: 10.1002/clc.23085. Epub 2018 Oct 25.
10
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
Circulation. 2020 Apr 28;141(17):1384-1392. doi: 10.1161/CIRCULATIONAHA.119.044059. Epub 2020 Mar 12.
引用本文的文献
1
An integrated bioinformatics approach for identification of key modulators and biomarkers involved in atrial fibrillation.
J Cardiovasc Thorac Res. 2025 Jun 28;17(2):109-120. doi: 10.34172/jcvtr.025.33347. eCollection 2025 Jun.
2
Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients.
Int Urol Nephrol. 2025 Mar;57(3):897-906. doi: 10.1007/s11255-024-04260-w. Epub 2024 Oct 28.
3
Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management.
Rev Cardiovasc Med. 2024 Apr 9;25(4):143. doi: 10.31083/j.rcm2504143. eCollection 2024 Apr.
4
Association between changes in renal function and clinical outcomes in anticoagulated atrial fibrillation patients with marginal renal function. A nationwide observational cohort study.
Front Cardiovasc Med. 2024 Jun 6;11:1423336. doi: 10.3389/fcvm.2024.1423336. eCollection 2024.
5
Polypharmacy in atrial fibrillation: A prospective analysis of mortality and ischemic stroke using the Clinical Practice Research Datalink.
J Arrhythm. 2023 Nov 27;40(1):47-56. doi: 10.1002/joa3.12961. eCollection 2024 Feb.
6
Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population-Based Study.
J Am Heart Assoc. 2023 Apr 18;12(8):e028496. doi: 10.1161/JAHA.122.028496. Epub 2023 Apr 17.
7
Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease: Practical Issues.
Anatol J Cardiol. 2022 Dec;26(12):857-863. doi: 10.5152/AnatolJCardiol.2022.2426.
8
Dialysis Mode and Associated Outcomes in Patients With End-Stage Renal Disease and Atrial Fibrillation: A 14-Year Nationwide Cohort Study.
J Am Heart Assoc. 2021 Jun 15;10(12):e019596. doi: 10.1161/JAHA.120.019596. Epub 2021 Jun 2.
9
Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients.
Front Cardiovasc Med. 2020 Jun 3;7:96. doi: 10.3389/fcvm.2020.00096. eCollection 2020.
10
Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):151-156. doi: 10.1007/s40292-020-00373-2. Epub 2020 Mar 25.
本文引用的文献
1
Concurrent renal dysfunction with ischemic heart disease is an important determinant for cardiac and cerebrovascular mortality in patients on chronic digoxin therapy for atrial fibrillation.
Kidney Res Clin Pract. 2018 Jun;37(2):130-137. doi: 10.23876/j.krcp.2018.37.2.130. Epub 2018 Jun 30.
2
Catheter Ablation for Atrial Fibrillation with Heart Failure.
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
3
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
4
Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system.
Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):850-9. doi: 10.1161/CIRCEP.112.972273.
5
Sympathetic nervous system: role in hypertension and in chronic kidney disease.
Curr Opin Nephrol Hypertens. 2012 Jan;21(1):46-51. doi: 10.1097/MNH.0b013e32834db45d.
6
Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fibrillation.
Heart Rhythm. 2011 Apr;8(4):583-9. doi: 10.1016/j.hrthm.2010.11.040. Epub 2010 Nov 29.
7
Sympathetic neural activity in hypertension and related diseases.
Am J Hypertens. 2010 Oct;23(10):1052-60. doi: 10.1038/ajh.2010.154. Epub 2010 Jul 22.
8
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
Circulation. 2006 Aug 1;114(5):397-403. doi: 10.1161/CIRCULATIONAHA.106.628347. Epub 2006 Jul 24.
9
The effect of digoxin on mortality and morbidity in patients with heart failure.
N Engl J Med. 1997 Feb 20;336(8):525-33. doi: 10.1056/NEJM199702203360801.
10
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.
J Clin Invest. 1990 Jun;85(6):1844-52. doi: 10.1172/JCI114644.
Zotero 插件